NYSCF CEO Susan L. Solomon was profiled in the April 2012 issue of Stem Cells Translational Medicine. In the profile, Ms. Solomon discussed the singular vision that first drove her to create a foundation to direct private funds to support human embryonic stem cell research, shielding scientists from the unpredictable valence of policy changes affecting public funding. The profile highlights the organization's rapid growth and research milestones over the past six years and sheds light on how NYSCF plans to overcome the remaining obstacles on the road to cures.
